ThinkCyte is Biotechnology in Japan that focus on Ghost Cytometry technology business. Founded in 2016. They cover business area such as developer, an image-base cell sort technology, single-cell analysis, research, diagnostic, therapeutic, advanced optic, machine learning, biotechnology, ultra-high throughput, content-rich analysis, a single cell level, discipline, drug discovery, cell therapy, their image, target cell, rare cell, real-time.
2016
( 8 years old in 2024 )
Ghost Cytometry Technology
-
U. Tokyo Entrepreneur Plaza
7-3-1 Hongo
Tokyo, Bunkyo-ku 113-0033
Japan
Private
developeran image-base cell sort technologysingle-cell analysisresearchdiagnostictherapeuticadvanced opticmachine learningbiotechnologyultra-high throughputcontent-rich analysisa single cell leveldisciplinedrug discoverycell therapytheir imagetarget cellrare cellreal-time
* We use standard office opening hours in near ThinkCyte's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
ThinkCyte is Biotechnology business from Japan that founded in 2016 (8 years old in 2024), ThinkCyte business is focusing on Ghost Cytometry Technology.
ThinkCyte headquarter office and corporate office address is located in U. Tokyo Entrepreneur Plaza 7-3-1 Hongo Tokyo, Bunkyo-ku 113-0033 Japan.
ThinkCyte was founded in Japan.
In 2024, ThinkCyte is currently focus on Ghost Cytometry technology sector.
Above is snippet of Google Trends for "Ghost Cytometry technology" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with ThinkCyte, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
